CCL2 and polycystic ovary syndrome: Pre-administration of KOK significantly decreased the increased levels of IL-1β, IL-6, IL-8, TNF-α, MCP-1, and iNOS; and increased the reduced mRNA expression of epidermal growth factor and TGF-β in PCOS ovaries.